Bär & Karrer advised UBS on the sale of its 50% stake in Swisscard. On 21 October 2024, the deal was finalized with the announcement that UBS Switzerland and American Express Swiss Holdings agreed to the sale
Tags :Laura Widmer
Bär & Karrer served as legal advisors on all matter of Swiss law to UBS in the sale of Credit Suisse Investment Partner (CSIP), indirectly held by UBS with a 62% majority stake, which was
On 30 September 2024, UBS Group AG closed the sale of its 100% holding in Credit Suisse Insurance Linked Strategies Ltd (“CSILS”) to the CSILS management team led by Niklaus Hilti. The respective agreement was signed in July 2024.
Aunetic, formerly Blika, a portfolio company of Main Capital and leading provider of governance software, has acquired all shares in LARI digital, a leading software provider that offers a cloud-based platform for legal and regulatory
The renowned global private schools group Cognita, with a community of more than 100 schools across 16 countries, has acquired the Swiss-based FOUR-FOREST Group from their founders. Offering education from nursery to secondary levels at three campuses,
Bär & Karrer advises Miele o the Establishment of a Joint Venture in the Fields of Infection Control and Life Science Miele and Metall Zug have reached an agreement outlining the establishment of a
Kohlberg Kravis Roberts (KKR) makes a significant investment into the Precipart Group, a renowned contract manufacturer of high-precision components to the medical, aerospace and industrial markets. KKR plans to support the company in its continued
Wüest Partner, on its growth path, has acquired a majority stake in Signa-Terre and 100% of Khephren. With this step,the group strengthens its position in the field of holistic sustainability solutions and digital products
Heizkurier Group, a portfolio company of Nord Holding, has acquired Suter Group, a supplier of mobile pellet heating and dehumidification solutions. With the acquisition, the company is implementing its growth and sustainability-focused strategy for Heizkurier
Novartis has completed the spin-off of Sandoz‘s generics and biosimilars business, with the result that Sandoz Group debuted as an independent, publicly traded company. Sandoz shares were successfully listed on the Swiss stock exchange,
